Clinical trial on the efficacy of exhaled carbon monoxide measurement in smoking cessation in primary health care

Joana Ripoll, Helena Girauta, Maria Ramos, David Medina-Bombardó, Agnès Pastor, Cristina Alvarez-Ossorio, Lucía Gorreto, Maria Esteva, Elena García, Ana Uréndez, Ana Buades, Elena Torres, Joana Ripoll, Helena Girauta, Maria Ramos, David Medina-Bombardó, Agnès Pastor, Cristina Alvarez-Ossorio, Lucía Gorreto, Maria Esteva, Elena García, Ana Uréndez, Ana Buades, Elena Torres

Abstract

Background: Smoking cessation is beneficial for our health at any point in life, both in healthy people and in people already suffering from a smoking-related disease. Any help to quit smoking can produce considerable benefits for Public Health. The purpose of the present study is to evaluate the efficacy of the CO-oximetry technique together with brief advice in smoking cessation, in terms of reduction of the number of cigarettes or in the variation of the motivation to quit smoking at month 12 compared with brief advice alone.

Methods/design: Randomised, parallel, single-blind clinical trial in a primary health care setting in Majorca (Spain). Smokers in contemplation or pre-contemplation phase will be included in the study.

Exclusion criteria: Smokers in preparation phase, subjects with a terminal illness or whose health status does not allow them to understand the study or complete the informed consent, and pregnant or breastfeeding women. The subjects will be randomly assigned to the control group (CG) or the intervention group (IG). The CG will receive brief advice, and the IG will receive brief advice together with a measurement of exhaled CO. There will be follow-up evaluations at 6 and 12 months after inclusion. 471 subjects will be needed per group in order to detect a difference between groups ≥ 5%.

Primary outcome: sustained smoking cessation (at 6 and 12 months) confirmed by urine cotinine test.

Secondary outcomes: point smoking cessation at 6 and 12 months both confirmed by urine cotinine analysis and self-reported, reduction in cigarette consumption, and variation in phase of smoking cessation.

Discussion: CO-oximetry is an inexpensive, non-invasive, fast technique that requires little technical training; making it a technique for risk assessment in smokers that can be easily applied in primary care and, if proven effective, could serve as a reinforcement aid in smoking cessation intervention activities.

Trial registration: Current Controlled Trials ISRCTN67499921.

References

    1. Ezzati M, López AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003;362:847–852. doi: 10.1016/S0140-6736(03)14338-3.
    1. Doll R, Bradford A. The mortality of doctors in relation to their smoking habits. BMJ. 1954;328:1451–1455.
    1. Edwards R. The problem of tobacco smoking. BMJ. 2004;328:217–219. doi: 10.1136/bmj.328.7433.217.
    1. Errard-Lalande G. Assisting smoking cessation. Rev Mal Respir. 2005;22(Pt 2):8S15–8S26.
    1. Rigotti NA. Treatment of tobacco use and dependence. New Engl J Med. 2002;346(7):506–512. doi: 10.1056/NEJMcp012279.
    1. Lancaster T, Stead LF. Self-help interventions for smoking cessation. Cochrane Database of Systematic Reviews. 2005. p. CD001118. pub2.
    1. Le Foll B, George TP. Treatment of tobacco dependence: integrating recent progress into practice. CMAJ. 2007;177(11):1373–1380. doi: 10.1503/cmaj.070627.
    1. Ramos M, Ripoll J, Estrades T, Socias I, Fe A, Duro R, González MJ, Servera M. Effectiveness of intensive group and individual interventions for smoking cessation in primary health care settings: a randomized trial. BMC Public Health. 2010;10(1):89. doi: 10.1186/1471-2458-10-89.
    1. Prochaska JO, DiClemente CC, Nocross JC. In search of how people change. Applications to addictive behaviors. Am Psychol. 1992;47(9):1102–1114.
    1. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database of Systematic Reviews. 2008. p. CD000165. pub3.
    1. Lancaster T, Stead LF. Physician advice for smoking cessation. Cochrane Database of Systematic Reviews. 2004. p. CD000165. pub2.
    1. Torrecilla M, Domínguez F, Torres A, Cabezas C, Jiménez CA, Barrueco M, Solano S, de Granda JI, Díaz-Maroto JL, Alonso J, Martínez ML, García S, de la Cruz E, Abengozar R, Ramos F, Ayesta J. Recomendaciones en el abordaje diagnóstico y terapéutico del fumador. Documento de consenso. Aten Primaria. 2002;30(5):310–317.
    1. Miller WR, Rollnick S. Motivational interviewing: preparing people to change additive behavior. Guilford, New York; 1991.
    1. Weinberger M, Green JY, Hamlin JJ, Jerin MJ. Health beliefs and smoking behavior. Am J Public Health. 1981;71:1251–1255.
    1. McClure JB. Are biomarkers a useful aid in smoking cessation. A review and analysis of the literature. Behav Med. 2001;27:37–41. doi: 10.1080/08964280109595770.
    1. Bize R, Burnand B, Mueller Y, Cornuz J. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database of Systematic Reviews. 2005. p. CD004705. pub2.
    1. Jarvis JM, Rusell MAH, Saloojee Y. Expired air carbon monoxide: a simple breath test of tobacco smoke intake. BMJ. 1980;2:484.
    1. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005;100:299–303. doi: 10.1111/j.1360-0443.2004.00995.x.
    1. Wald NJ, Howard S, Smith PG, Kjeldsen K. Association between atherosclerotic disease and carboxyhaemoglobin levels in tobacco smoke. BMJ. 1973;1:761–765. doi: 10.1136/bmj.1.5856.761.
    1. Jamrozik K, Vessey M, Fowler G, Wald N, Parker G, Van Vunakis H. Controlled trial of three different anntismoking interventions in general practice. Br Med J. 1984;288(6429):1499–1503. doi: 10.1136/bmj.288.6429.1499.
    1. Sanders D, Fowler G, Mant D, Fuller A, Jones L, Marzillier J. Randomized controlled trial of anti-smoking advice by nurses in general practice. J R Coll Gen Pract. 1989;39:273–276.
    1. Audrain J, Boyd NR, Roth J, Main D, Caporaso NE, Lerman C. Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. Addict Behav. 1997;22(6):741–751. doi: 10.1016/S0306-4603(97)00060-9.
    1. Middleton ET, Morice AH. Breath Carbon monoxide as an indication for smoking habit. Chest. 2000;117:758–763. doi: 10.1378/chest.117.3.758.
    1. Cabezas C, Martin C, Granollers S. et al.Effectiveness of a stepped primary care smoking cessation intervention (ISTAPS study): design of a cluster randomised trial. BMC Public Health. 2009;9:48. doi: 10.1186/1471-2458-9-48.

Source: PubMed

3
Iratkozz fel